image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Crest Nicholson

January 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • CRST
  • Price:
  • 359p
Although mortgage approvals have plunged, housebuilder Crest Nicholson said full year profits will be marginally ahead of consensus forecasts and while cost inflation is a challenge, it’s mitigated by raising prices.Interestingly, the group has introduced new medium-term targets to achieve in excess of 3,000 units annually by FY’24 and 4,200 by FY’26. To that end, plans to open new divisions in Yorkshire and East Anglia next year have been implemented.Eps is forecast to rise sharply from an expected 31p this year to 41p and 50p in ’22 and ’23, dropping the prospective PE to 8.7 and then 7.2. Highlighted at just 198p in November ‘20, I am a buyer on dips. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X